Laureato in chimica all’Università degli Studi di Milano, ha svolto un Postdoc presso la University of Tennesse a Knoxville (Usa) con uno studio su nanoparticelle per uso biologico. È Professore Ordinario di Biochimica e Biologia Molecolare presso la Facoltà di Medicina dell’Università degli Studi di Milano-Bicocca ed è Direttore del Nanomib, il Centro interdipartimentale di Nanomedicina presso la medesima università. È stato coordinatore del progetto europeo "NAD, Nanoparticles for therapy and dlagnosis of Alzheimer disease”. Ha coordinato diversi altri progetti ed è membro di diversi comitati e organizzazioni scientifiche.
%22%20transform%3D%22translate(.7%20.7)%20scale(1.36719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-116.4%20135.2%2016.3)%20scale(33.35349%20116.56395)%22%2F%3E%3Cellipse%20fill%3D%22%23464a25%22%20cx%3D%22237%22%20cy%3D%22181%22%20rx%3D%2254%22%20ry%3D%2254%22%2F%3E%3Cellipse%20fill%3D%22%232b1b6e%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-3.8%20596.4%20-1484.2)%20scale(202.95075%2045.21637)%22%2F%3E%3Cellipse%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(11.36146%2019.28838%20-160.39754%2094.47916%20123%20181)%22%2F%3E%3Cellipse%20fill%3D%22%23000038%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-13.4%20542.3%20-506.3)%20scale(103.48492%2031.81211)%22%2F%3E%3Cellipse%20fill%3D%22%232a1a6c%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(157.7%20-6.8%2077.9)%20scale(29.4631%20161.76634)%22%2F%3E%3Cellipse%20fill%3D%22%23000036%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(77.8%20-42.7%20112.7)%20scale(51.99697%2035.43702)%22%2F%3E%3Cpath%20fill%3D%22%2351524c%22%20d%3D%22M211%20158h45v24h-45z%22%2F%3E%3Cpath%20d%3D%22M159.2%20133.4l29.3%2069-61.7%2026.2-29.3-69z%22%2F%3E%3Cpath%20fill%3D%22%2300003a%22%20d%3D%22M23.4%20109.2l37%2066.2%20161.1-67.6L271%2057z%22%2F%3E%3Cellipse%20fill%3D%22%231f1f1e%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-17.76755%2027.55572%20-13.25252%20-8.54504%20197.7%20164.1)%22%2F%3E%3Cellipse%20fill%3D%22%2322175b%22%20cx%3D%22187%22%20cy%3D%2258%22%20rx%3D%2230%22%20ry%3D%2223%22%2F%3E%3Cellipse%20fill%3D%22%231c1c1e%22%20cx%3D%22238%22%20cy%3D%22143%22%20rx%3D%2238%22%20ry%3D%2214%22%2F%3E%3Cpath%20fill%3D%22%23251863%22%20d%3D%22M7.8%2088.3l14.7-22.6%2027.7%2018-14.7%2022.6z%22%2F%3E%3Cellipse%20cx%3D%22254%22%20cy%3D%22107%22%20rx%3D%2226%22%20ry%3D%2221%22%2F%3E%3Cpath%20fill%3D%22%23211659%22%20d%3D%22M108%2093L-16-7%20270%203z%22%2F%3E%3Cpath%20d%3D%22M162.3%20156l-7.5-19.6%2043-16.4%207.4%2019.6z%22%2F%3E%3Cellipse%20fill%3D%22%2300003a%22%20cx%3D%2278%22%20cy%3D%22181%22%20rx%3D%2221%22%20ry%3D%22100%22%2F%3E%3Cellipse%20fill%3D%22%2321165a%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(15.55057%2025.8122%20-20.4383%2012.31307%2033.2%20161)%22%2F%3E%3Cellipse%20fill%3D%22%23000034%22%20cx%3D%22243%22%20cy%3D%2273%22%20rx%3D%2222%22%20ry%3D%2216%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
%22%20transform%3D%22translate(.7%20.7)%20scale(1.36719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23000400%22%20cx%3D%2211%22%20cy%3D%22117%22%20rx%3D%2248%22%20ry%3D%2248%22%2F%3E%3Cpath%20fill%3D%22%23bee4f2%22%20d%3D%22M133.9%208l-18%2062.6-127.8-36.7%2018-62.5z%22%2F%3E%3Cellipse%20fill%3D%22%23c35275%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-114.3%20108.5%20-49.3)%20scale(52.85252%20104.75271)%22%2F%3E%3Cellipse%20fill%3D%22%236a3a4a%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(147.5%2086.6%2069.7)%20scale(55.83263%2041.51825)%22%2F%3E%3Cellipse%20fill%3D%22%233d4944%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(32.86405%20-14.06467%2037.77115%2088.25752%2056%20144.7)%22%2F%3E%3Cellipse%20fill%3D%22%2386ebff%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(6.1%2014%20261.8)%20scale(49.00276%2025.83934)%22%2F%3E%3Cellipse%20fill%3D%22%23ab8990%22%20cx%3D%22115%22%20cy%3D%2238%22%20rx%3D%2250%22%20ry%3D%2250%22%2F%3E%3Cpath%20fill%3D%22%23050606%22%20d%3D%22M-29.5%20111.4L6%2080.6l29.5%2034L0%20145.4z%22%2F%3E%3Cellipse%20fill%3D%22%23b4496c%22%20cx%3D%22255%22%20cy%3D%2289%22%20rx%3D%2237%22%20ry%3D%2233%22%2F%3E%3Cellipse%20fill%3D%22%237b8b83%22%20cx%3D%22136%22%20cy%3D%22141%22%20rx%3D%2248%22%20ry%3D%2248%22%2F%3E%3Cellipse%20fill%3D%22%234c6059%22%20cx%3D%22186%22%20cy%3D%22107%22%20rx%3D%2234%22%20ry%3D%2225%22%2F%3E%3Cellipse%20fill%3D%22%23bd758e%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-87.18849%20-31.5618%209.71871%20-26.84764%20198.2%202.4)%22%2F%3E%3Cellipse%20fill%3D%22%237f8f87%22%20cx%3D%22220%22%20cy%3D%22163%22%20rx%3D%2242%22%20ry%3D%2242%22%2F%3E%3Cellipse%20fill%3D%22%23565d5a%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(5.46128%2014.4564%20-41.79816%2015.79033%2018.6%20172.6)%22%2F%3E%3Cpath%20fill%3D%22%2388918a%22%20d%3D%22M144%20117L-16%2036l83-3z%22%2F%3E%3Cellipse%20fill%3D%22%2391c4ff%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(97.8%2020.6%2018)%20scale(23.6375%2041.24481)%22%2F%3E%3Cellipse%20fill%3D%22%23bdc4b8%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-1.12595%20-13.266%2042.72362%20-3.62616%2010.8%2033.9)%22%2F%3E%3Cpath%20fill%3D%22%23db93ac%22%20d%3D%22M102%2051l33-26-26%2067z%22%2F%3E%3Cpath%20fill%3D%22%2365736d%22%20d%3D%22M110.1-3l25-1%20.8%2021-25%201z%22%2F%3E%3Cellipse%20fill%3D%22%238f425d%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(70.82803%207.88683%20-2.33696%2020.98714%20218.1%2067)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Tutti gli articoli
ANTI-ALZHEIMER/ Ecco la nuova strada per la produzione dei nano-farmaci
Si chiama AmypoPharma lo spin-off nato con l’obiettivo di sviluppare un farmaco anti-Alzheimer basato sugli Amyposomes. Intervista a MASSIMO MASSERINI
BIOSCIENZE/ La Bicocca schiera la task force della nanomedicina (anche contro l’Alzheimer)
MASSIMO MASSERINI parla del lavoro che si svolgerà al Nanomib, il Centro interdipartimentale di Nanomedicina inaugurato nei giorni scorsi presso l’Università ...
